Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current Medical Research and Opinion

• Publication date

  2018-01-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/03007995.2017.1410471PMID 29179595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.

  2017cited by this paper
• Efficacy and safety of aripiprazole lauroxil in schizophrenic patients presenting with severe psychotic symptoms during an acute exacerbation.

  2017cited by this paper
• A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.

  2015cited by this paper
• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

  2015cited by this paper
• Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study.

  2014cited by this paper
• Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks

  2014cited by this paper
• Humanistic burden in schizophrenia: a literature review.

  2014cited by this paper
• Evidence Synthesis for Decision Making 3

  2013cited by this paper
• Evidence Synthesis for Decision Making 1

  2013cited by this paper
• Evidence Synthesis for Decision Making Inconsistency in Networks of Evidence Based on Randomized Controlled Trials.

  2013cited by this paper
• Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

  2013cited by this paper
• Evidence Synthesis for Decision Making 2

  2013cited by this paper
• Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments

  2013cited by this paper
• Evidence Synthesis for Decision Making 4

  2013cited by this paper
• Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

  2013cited by this paper
• Evidence Synthesis for Decision Making 1: Introduction. Medical Decision Making,

  2013cited by this paper
• Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.

  2012influential reference
• Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment

  2011cited by this paper
• Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.

  2011cited by this paper
• A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.

  2011cited by this paper
• The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

  2009cited by this paper
• Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.

  2007cited by this paper
• Simultaneous comparison of multiple treatments: combining direct and indirect evidence

  2005cited by this paper
• Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

  2002cited by this paper

• Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

  2021cites this paper
• The use of carbamazepine to expedite the metabolism of a long‐acting aripiprazole injection

  2021cites this paper
• From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs)

  2020cites this paper
• Antipsychotiques à Action Prolongée: Révision de l’algorithme QAAPAPLE

  2019cites this paper